4.5 Editorial Material

Structure-based drug discovery by targeting N-glycan biosynthesis, dolichyl-phosphate N-acetylglucosaminephosphotransferase

Related references

Note: Only part of the references are listed.
Article Chemistry, Organic

Semisynthesis of an Anticancer DPAGT1 Inhibitor from a Muraymycin Biosynthetic Intermediate

Katsuhiko Mitachi et al.

ORGANIC LETTERS (2019)

Article Biochemistry & Molecular Biology

GlcNAc-l-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation

Jiho Yoo et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

Article Biochemistry & Molecular Biology

GlcNAc-l-P-transferase-tunicamycin complex structure reveals basis for inhibition of N-glycosylation

Jiho Yoo et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)

Article Chemistry, Multidisciplinary

Novel FR-900493 Analogues That Inhibit the Outgrowth of Clostridium difficile Spores

Katsuhiko Mitachi et al.

ACS OMEGA (2018)

Editorial Material Oncology

Cancer cell associated glycans as targets for immunotherapy

Mireille Vankemmelbeke et al.

ONCOIMMUNOLOGY (2016)

Article Genetics & Heredity

Mutations in DPAGT1 Cause a Limb-Girdle Congenital Myasthenic Syndrome with Tubular Aggregates

Katsiaryna Belaya et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2012)

Article Biochemistry & Molecular Biology

N-glycan biosynthesis inhibitors induce in vitro anticancer activity in colorectal cancer cells

Julio Cesar Madureira de-Freitas-Junior et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2012)

Article Biochemistry & Molecular Biology

N-Glycosylation Gene DPAGT1 Is a Target of the Wnt/β-Catenin Signaling Pathway

Pritam K. Sengupta et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Review Biochemistry & Molecular Biology

Cadherins and cancer: how does cadherin dysfunction promote tumor progression?

A. Jeanes et al.

ONCOGENE (2008)